Logo image of LFWD

LIFEWARD LTD (LFWD) Stock Overview

USA - NASDAQ:LFWD - IL0011331076 - Common Stock

0.648 USD
0 (-0.31%)
Last: 10/24/2025, 8:00:02 PM
0.6749 USD
+0.03 (+4.15%)
After Hours: 10/24/2025, 8:00:02 PM

LFWD Key Statistics, Chart & Performance

Key Statistics
Market Cap10.17M
Revenue(TTM)24.43M
Net Income(TTM)-29758000
Shares15.70M
Float15.42M
52 Week High4
52 Week Low0.5
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-2.01
PEN/A
Fwd PEN/A
Earnings (Next)11-18 2025-11-18
IPO2014-09-12
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


LFWD short term performance overview.The bars show the price performance of LFWD in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40 -50

LFWD long term performance overview.The bars show the price performance of LFWD in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of LFWD is 0.648 USD. In the past month the price decreased by -11.99%. In the past year, price decreased by -72.54%.

LIFEWARD LTD / LFWD Daily stock chart

LFWD Latest News, Press Relases and Analysis

LFWD Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 25.42 220.78B
ISRG INTUITIVE SURGICAL INC 63.47 195.91B
BSX BOSTON SCIENTIFIC CORP 34.27 149.82B
SYK STRYKER CORP 29.71 145.96B
MDT MEDTRONIC PLC 16.94 120.15B
BDX BECTON DICKINSON AND CO 13.02 53.26B
IDXX IDEXX LABORATORIES INC 53.36 51.27B
EW EDWARDS LIFESCIENCES CORP 29.61 44.68B
RMD RESMED INC 27.17 37.87B
GEHC GE HEALTHCARE TECHNOLOGY 16.77 35.68B
PHG KONINKLIJKE PHILIPS NVR- NY 17.26 27.76B
DXCM DEXCOM INC 41.37 27.58B

About LFWD

Company Profile

LFWD logo image Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm is engaged in designing, developing, and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk again. The firm offers an exoskeleton that uses its tilt-sensor technology and an onboard computer and motion sensors to drive motorized legs that power movement. Lifeward designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, having the use of their upper bodies and arms. The firm offers multiple products: ReWalk Personal, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. ReWalk Personal is designed for everyday use by paraplegic individuals at home and in their communities and is custom-fitted for each user. Lifeward Rehabilitation products are for use by paraplegia patients in the clinical rehabilitation environment.

Company Info

LIFEWARD LTD

3 Hatnufa st. 6th fl., P.O. Box 161

Yokneam IL

Employees: 80

LFWD Company Website

LFWD Investor Relations

Phone: 97249590123

LIFEWARD LTD / LFWD FAQ

Can you describe the business of LIFEWARD LTD?

Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm is engaged in designing, developing, and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk again. The firm offers an exoskeleton that uses its tilt-sensor technology and an onboard computer and motion sensors to drive motorized legs that power movement. Lifeward designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, having the use of their upper bodies and arms. The firm offers multiple products: ReWalk Personal, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. ReWalk Personal is designed for everyday use by paraplegic individuals at home and in their communities and is custom-fitted for each user. Lifeward Rehabilitation products are for use by paraplegia patients in the clinical rehabilitation environment.


What is the stock price of LIFEWARD LTD today?

The current stock price of LFWD is 0.648 USD. The price decreased by -0.31% in the last trading session.


Does LFWD stock pay dividends?

LFWD does not pay a dividend.


What is the ChartMill technical and fundamental rating of LFWD stock?

LFWD has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


What is the Price/Earnings (PE) ratio of LIFEWARD LTD (LFWD)?

LIFEWARD LTD (LFWD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.01).


Would investing in LIFEWARD LTD be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on LFWD.


Can you provide the growth outlook for LIFEWARD LTD?

The Revenue of LIFEWARD LTD (LFWD) is expected to decline by -1.98% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


LFWD Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to LFWD. When comparing the yearly performance of all stocks, LFWD is a bad performer in the overall market: 95.95% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

LFWD Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to LFWD. The financial health of LFWD is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

LFWD Financial Highlights

Over the last trailing twelve months LFWD reported a non-GAAP Earnings per Share(EPS) of -2.01. The EPS increased by 34.1% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -111.13%
ROE -196.94%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-16%
Sales Q2Q%-14.66%
EPS 1Y (TTM)34.1%
Revenue 1Y (TTM)4.96%

LFWD Forecast & Estimates

8 analysts have analysed LFWD and the average price target is 5.61 USD. This implies a price increase of 765.74% is expected in the next year compared to the current price of 0.648.

For the next year, analysts expect an EPS growth of 43.2% and a revenue growth -1.98% for LFWD


Analysts
Analysts82.5
Price Target5.61 (765.74%)
EPS Next Y43.2%
Revenue Next Year-1.98%

LFWD Ownership

Ownership
Inst Owners2.9%
Ins Owners2.07%
Short Float %10.06%
Short Ratio4.48